Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

Sibylle Loibl, Michael Untch, Nicole Burchardi, Jens Huober, Bruno Valentin Sinn, Jens‐Uwe Blohmer and 17 more

Rank
12 of 4,622
Percentile
top 0.3%
Where
Annals of Oncology, 2019
Citations
698

From the 2019 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.